Familial Hypercholesterolaemia and elevated lipopretein-a [Lp(a)】are the most common inherited lipid conditions in Europe. They are major drivers of premature heart attacks, strokes and other cardiovascular diseases, yet remain largely invisible to citizens and in public health strategies. Around one in 300 people live with FH and one in five with high Lp(a).
?
424 ΓΣΝΕ
Academic / research · Greece
2
positions filed
in the 687 files tracked
1
legislative file
of 687 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 687 consultation files tracked so far (60,344 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track 424 in PolicySpeak: request access →
Work at 424 ΓΣΝΕ? so we know who speaks for it.
Their record over time
424 ΓΣΝΕ filed 2 positions on 16 Sept 2025, across 1 of the 687 legislative files tracked here.
What they argued
High Lipotein(a), [Lp(a)] is one of the strongest inherited and causal risk factors for cardiovascular disease, affecting one in five Europeans. Despite this prevalence, testing rates remain at only 12%. Most citizens are unaware of their elevated risk, leaving prevention opportunities untapped and healthcare systems burdened by avoidable heart attacks, strokes, and aortic valve disease.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put 424 ΓΣΝΕ next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from 424 ΓΣΝΕ’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.